- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02106702
The Navigator Project (NAV)
June 15, 2015 updated by: University of California, San Francisco
Navigator-Enhanced Case Management for HIV-Infected Jail Inmates Reentering the Community
Each year, there are over 600 unduplicated HIV-infected persons incarcerated in the San Francisco jail.
Two thirds of those released with HIV-focused discharge planning are reincarcerated within one year.
More than half of HIV-infected jail inmates are diagnosed with mental health conditions severe enough to require medication and a similar proportion report substance use disorders at the time of detention.
While some community-based services exist, there remains a critical need to improve linkages to care and adherence to care plans for HIV-infected adults as they move between community and jail.
The Navigator Project is a five-year randomized study that will test the effectiveness of an intensive enhanced case management intervention to reduce sex and drug-related HIV transmission risk; increase HIV medication adherence; reduce drug dependence; and reduce reincarceration.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
271
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Francisco, California, United States, 94102
- Tenderloin Clinical Research Foundation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Detention in the San Francisco jail system
- Confirmed HIV infection
- Lifetime history of ever having met standardized criteria for drug or alcohol addiction
- Likely release back into San Francisco without transfer to another facility
- Agreement to work with Forensic AIDS Project to plan post-release care
- Able and willing to provide informed consent
- Not scheduled for release within 36 hours
Exclusion Criteria:
- Undocumented HIV status
- Inability to speak English or Spanish
- Unable or unwilling to provide informed consent
- Not under routine level of jail security
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: FAP counseling
Control arm utilizing the standard of care: access to services provided by the Forensic AIDS Project for up to 90 days after release
|
The Forensics AIDS Project provides primary care to HIV-infected detainees, as well as up to 90 post-release case-management services which include discharge planning.
|
Experimental: Navigator enhanced case-management
Experimental arm: access to Navigator enhanced case-management services for one year after release
|
Patient navigators are non-clinical, paraprofessional peers who are HIV-infected and have lifetime histories of detention and substance abuse.
Working with the patient, they facilitate adherence to a comprehensive care plan designed to address clients' multiple risks and needs.
Patients have access to Navigator services for one year after study enrollment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
substance use
Time Frame: 2 months, 6 months, 12 months
|
change from baseline in self-reported drug and alcohol use, measured by a survey tool, and actual use of five drugs (methamphetamine, cocaine, tetrahydrocannabinol, opiates, and benzodiazepines), measured by a urine screen, at three time points each
|
2 months, 6 months, 12 months
|
recidivism
Time Frame: 12 months
|
number of times re-detained during the twelve-month study period, collected from jail records
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
sexual risk behavior
Time Frame: 2 months, 6 months, 12 months
|
change from baseline in self-reported sexual risk behaviors, measured by a survey tool at three time points after the initial detention
|
2 months, 6 months, 12 months
|
adherence to HIV medications
Time Frame: 2 months, 6 months, 12 months
|
change from baseline in self-reported adherence (as a %) to antiretroviral therapy, measured by a survey tool at three time points after the initial detention
|
2 months, 6 months, 12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
housing
Time Frame: 2 months, 6 months, 12 months
|
change from baseline in self-reported housing status, measured by a survey tool at three time points after the initial detention
|
2 months, 6 months, 12 months
|
medical coverage
Time Frame: 2 months, 6 months,12 months
|
change from baseline in self-reported insurance coverage, measured by a survey tool at three time points after the initial detention, and use of community health services and jail health services, measured continuously via a community database for 12 months after the initial detention
|
2 months, 6 months,12 months
|
needle use
Time Frame: 2 months, 6 months, 12 months
|
change from baseline in self-reported needle-use and needle-sharing, measured by a survey tool at three time points after the initial detention
|
2 months, 6 months, 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Janet J Myers, PhD, MPH, University of California, San Francisco
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2010
Primary Completion (Actual)
June 1, 2014
Study Completion (Actual)
June 1, 2014
Study Registration Dates
First Submitted
April 1, 2014
First Submitted That Met QC Criteria
April 3, 2014
First Posted (Estimate)
April 8, 2014
Study Record Updates
Last Update Posted (Estimate)
June 16, 2015
Last Update Submitted That Met QC Criteria
June 15, 2015
Last Verified
June 1, 2015
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- R01DA027209 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CDC FoundationGilead SciencesUnknownHIV Preexposure Prophylaxis | HIV ChemoprophylaxisUnited States
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... and other collaboratorsRecruiting
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Fenway Community Health; Tuberculosis...CompletedHIV/STI Risk | HIV/STI IncidenceUnited States, India
-
Hospital Clinic of BarcelonaCompletedIntegrase Inhibitors, HIV; HIV PROTEASE INHIBSpain
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
University of WashingtonNational Institute of Mental Health (NIMH)RecruitingHIV Prevention | HIV Preexposure Prophylaxis | ImplementationKenya
Clinical Trials on Forensic AIDS Project
-
Centers for Disease Control and PreventionUniversity of Minnesota; The Fenway Institute; AIDS Action Committee of Massachusetts and other collaboratorsCompletedHIV Prevention | STD PreventionUnited States
-
Adiyaman University Research HospitalCompleted
-
Sussex Partnership NHS Foundation TrustWithdrawnPersonality DisorderUnited Kingdom
-
University of KonstanzVivo international e.V.; Psychologues sans Frontières Burundi; Action on Armed...CompletedAggression | Depression | Posttraumatic Stress DisorderBurundi
-
University of KonstanzVivo international e.V.; Psychologues sans Frontières Burundi; Université Lumière...CompletedPosttraumatic Stress Disorder | Aggressive BehaviorBurundi
-
Utrecht UniversityDe WaagRecruitingAggression | Conduct Disorder | Behavioral Disorder | Antisocial BehaviorNetherlands
-
University of RochesterNational Institute of Mental Health (NIMH)CompletedPsychotic DisordersUnited States
-
Harvard UniversityCompletedDepression | Stress | AnxietyUnited States
-
Children's National Research InstituteChildren's Hospital ColoradoEnrolling by invitation
-
Harvard UniversityCompletedDepression | Stress | AnxietyUnited States